Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for PMVP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 10.57M
March 31, 2026 8.595M
December 31, 2025 11.85M
September 30, 2025 12.84M
June 30, 2025 12.25M
March 31, 2025 10.50M
December 31, 2024 15.21M
September 30, 2024 25.59M
June 30, 2024 23.22M
March 31, 2024 24.20M
December 31, 2023 26.46M
September 30, 2023 23.42M
June 30, 2023 24.41M
March 31, 2023 23.79M
Date Value
December 31, 2022 24.28M
September 30, 2022 23.79M
June 30, 2022 23.59M
March 31, 2022 23.16M
December 31, 2021 23.01M
September 30, 2021 19.23M
June 30, 2021 18.06M
March 31, 2021 6.098M
December 31, 2020 6.41M
September 30, 2020 5.476M
June 30, 2020 174.11M
March 31, 2020
December 31, 2019 173.51M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B
Anika Therapeutics, Inc. 46.19M
Savara, Inc. 48.48M
Vericel Corp. 132.82M

Total Liabilities (Quarterly) Related Metrics